Continuous Glucose Monitoring gives us lots of data, and various attempts have been made to distill it down into simple metrics. This is a difficult job as there can be a huge depth of data available in there, which can be lost if we only look at high level numbers. But people are used to …
What are “diabetes complications”? This is a term I have real problems with: it’s misleading, and has unfortunate impacts on everyone. I tend to think of there not actually being any such thing as a “diabetes complication”. There’s usually nothing “diabetic” about health complications. What are people referring to? Basically, at a crude level it’s about …
Recently I spent a day participating in a training course for endocrinology registrars (i.e. doctors). It was the Practical Skills Course for Endocrinology & General Medicine Advanced Trainees run by the Australian Diabetes Society. I’ve participated in this course for several years now. I was there as a consumer/demonstrator to help educate the attendees on things like …
News recently emerged about a safety recall of Medtronic insulin pumps in the US. News spread quickly across the internet, but an Australian perspective might be useful. It’s a recall through the US Food and Drug Adminstration, and thus does not apply to Australia. The pumps affected are the 630G and 670G pumps (manufactured during …
As I’ve written before, my own glycaemia has been described by some doctors as “approaching normoglycaemia”, and my last lab HbA1c result came in at 33 mmol/mol (5.2%). I’m not going to pretend that I’m “normal” (and I’m not the example in this article) but personally I have been feeling that my BG profile has …
As I wrote last month I was recently diagnosed with atheroschlerosis, with two partial blockages in arteries around my heart. Although my lipid profile has always been regarded as “low risk”, something developed at some point over the past years. Without having a heart attack, these narrowings were discovered by non-invasive testing (starting with a stress …